Hardy Kornfeld to Case-Control Studies
This is a "connection" page, showing publications Hardy Kornfeld has written about Case-Control Studies.
Connection Strength
0.184
-
Vanamudhu A, Viswanathan V, Mohan G, Krishna Rao N, Thiruvengadam K, Hissar S, Permal Kannabiran B, Babu S, Kornfeld H, Pavan Kumar N. Prognostic utility of immune biomarkers for identifying individuals at risk of unfavourable treatment outcomes in pulmonary tuberculosis. Front Immunol. 2026; 17:1928573.
Score: 0.048
-
Nancy Pandiarajan A, Kumar NP, Moideen K, Thiruvengadam K, Hissar S, Sivakumar S, Bethunaickan R, Viswanathan V, Kornfeld H, Babu S. Association of Altered Baseline Hematological Parameters with Adverse Tuberculosis Treatment Outcomes. Pathogens. 2025 Feb 04; 14(2).
Score: 0.043
-
Kumar NP, Moideen K, Nancy A, Viswanathan V, Thiruvengadam K, Sivakumar S, Hissar S, Nair D, Banurekha VV, Kornfeld H, Babu S. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis. JAMA Netw Open. 2020 12 01; 3(12):e2027754.
Score: 0.032
-
Kumar NP, Moideen K, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Hissar S, Kornfeld H, Babu S. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy. BMC Infect Dis. 2019 Dec 09; 19(1):1039.
Score: 0.030
-
Kumar NP, Moideen K, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Natarajan M, Kornfeld H, Babu S. Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis. Sci Rep. 2019 12 03; 9(1):18217.
Score: 0.030